Clinical challenges in lipid disorders:
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Oxford
Clinical Pub.
©2008
|
| Schriftenreihe: | Clinical challenges
|
| Schlagworte: | |
| Online-Zugang: | FAW01 FAW02 Volltext |
| Beschreibung: | Includes bibliographical references and index 7. Metabolism of apolipoprotein B-100-containing lipoproteins in dyslipidaemias8. Sex-specific aspects of dyslipidaemia and atherosclerosis; Part III: Prevention and treatment strategies; 9. New clinical trials oflipid-regulating agents; 10. Genetics of dyslipidaemia andcoronary risk (personalized lipid-lowering treatment); 11. Application of proteomic, metabolomic and lipidomic approaches to coronary heart disease risk prediction; 12. N. Lipid disorders are highly heterogeneous and widely prevalent throughout the world. Dyslipidemia is an important risk factor for atherosclerotic disease and its clinical sequelae, including myocardial infarction, ischemic stroke, and death. The impact of dyslipidemia treatment on risk for cardiovascular disease is one of the most intensively studied issues in all of medicine. This volume is an innovative approach to the identification and management of lipid disorders. Organized as a series of questions, each chapter presents a detailed yet accessible discussion of the problems posed. The ques |
| Beschreibung: | 1 Online-Ressource (xii, 297 pages) |
| ISBN: | 1846920299 1846925916 9781846920295 9781846925917 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043154773 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s2008 |||| o||u| ||||||eng d | ||
| 020 | |a 1846920299 |9 1-84692-029-9 | ||
| 020 | |a 1846925916 |c electronic bk. |9 1-84692-591-6 | ||
| 020 | |a 9781846920295 |9 978-1-84692-029-5 | ||
| 020 | |a 9781846925917 |c electronic bk. |9 978-1-84692-591-7 | ||
| 035 | |a (OCoLC)270110930 | ||
| 035 | |a (DE-599)BVBBV043154773 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 616.3997 |2 22 | |
| 100 | 1 | |a Toth, Peter P. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Clinical challenges in lipid disorders |c edited by Peter P. Toth and Domenic A. Sica |
| 264 | 1 | |a Oxford |b Clinical Pub. |c ©2008 | |
| 300 | |a 1 Online-Ressource (xii, 297 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Clinical challenges | |
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a 7. Metabolism of apolipoprotein B-100-containing lipoproteins in dyslipidaemias8. Sex-specific aspects of dyslipidaemia and atherosclerosis; Part III: Prevention and treatment strategies; 9. New clinical trials oflipid-regulating agents; 10. Genetics of dyslipidaemia andcoronary risk (personalized lipid-lowering treatment); 11. Application of proteomic, metabolomic and lipidomic approaches to coronary heart disease risk prediction; 12. N. | ||
| 500 | |a Lipid disorders are highly heterogeneous and widely prevalent throughout the world. Dyslipidemia is an important risk factor for atherosclerotic disease and its clinical sequelae, including myocardial infarction, ischemic stroke, and death. The impact of dyslipidemia treatment on risk for cardiovascular disease is one of the most intensively studied issues in all of medicine. This volume is an innovative approach to the identification and management of lipid disorders. Organized as a series of questions, each chapter presents a detailed yet accessible discussion of the problems posed. The ques | ||
| 650 | 7 | |a MEDICAL / Endocrinology & Metabolism |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Nutrition |2 bisacsh | |
| 650 | 7 | |a Lipids / Metabolism / Disorders |2 fast | |
| 650 | 4 | |a Dyslipidemias / diagnosis | |
| 650 | 4 | |a Dyslipidemias / therapy | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Lipids |x Metabolism |x Disorders | |
| 700 | 1 | |a Sica, Domenic A. |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=244612 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028578964 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=244612 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=244612 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175618680553472 |
|---|---|
| any_adam_object | |
| author | Toth, Peter P. |
| author_facet | Toth, Peter P. |
| author_role | aut |
| author_sort | Toth, Peter P. |
| author_variant | p p t pp ppt |
| building | Verbundindex |
| bvnumber | BV043154773 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)270110930 (DE-599)BVBBV043154773 |
| dewey-full | 616.3997 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.3997 |
| dewey-search | 616.3997 |
| dewey-sort | 3616.3997 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02976nmm a2200493zc 4500</leader><controlfield tag="001">BV043154773</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2008 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1846920299</subfield><subfield code="9">1-84692-029-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1846925916</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">1-84692-591-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781846920295</subfield><subfield code="9">978-1-84692-029-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781846925917</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-1-84692-591-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)270110930</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043154773</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.3997</subfield><subfield code="2">22</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Toth, Peter P.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Clinical challenges in lipid disorders</subfield><subfield code="c">edited by Peter P. Toth and Domenic A. Sica</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford</subfield><subfield code="b">Clinical Pub.</subfield><subfield code="c">©2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xii, 297 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Clinical challenges</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">7. Metabolism of apolipoprotein B-100-containing lipoproteins in dyslipidaemias8. Sex-specific aspects of dyslipidaemia and atherosclerosis; Part III: Prevention and treatment strategies; 9. New clinical trials oflipid-regulating agents; 10. Genetics of dyslipidaemia andcoronary risk (personalized lipid-lowering treatment); 11. Application of proteomic, metabolomic and lipidomic approaches to coronary heart disease risk prediction; 12. N.</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Lipid disorders are highly heterogeneous and widely prevalent throughout the world. Dyslipidemia is an important risk factor for atherosclerotic disease and its clinical sequelae, including myocardial infarction, ischemic stroke, and death. The impact of dyslipidemia treatment on risk for cardiovascular disease is one of the most intensively studied issues in all of medicine. This volume is an innovative approach to the identification and management of lipid disorders. Organized as a series of questions, each chapter presents a detailed yet accessible discussion of the problems posed. The ques</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Endocrinology & Metabolism</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Nutrition</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Lipids / Metabolism / Disorders</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Dyslipidemias / diagnosis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Dyslipidemias / therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lipids</subfield><subfield code="x">Metabolism</subfield><subfield code="x">Disorders</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sica, Domenic A.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=244612</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028578964</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=244612</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=244612</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV043154773 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:19:09Z |
| institution | BVB |
| isbn | 1846920299 1846925916 9781846920295 9781846925917 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028578964 |
| oclc_num | 270110930 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (xii, 297 pages) |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2008 |
| publishDateSearch | 2008 |
| publishDateSort | 2008 |
| publisher | Clinical Pub. |
| record_format | marc |
| series2 | Clinical challenges |
| spelling | Toth, Peter P. Verfasser aut Clinical challenges in lipid disorders edited by Peter P. Toth and Domenic A. Sica Oxford Clinical Pub. ©2008 1 Online-Ressource (xii, 297 pages) txt rdacontent c rdamedia cr rdacarrier Clinical challenges Includes bibliographical references and index 7. Metabolism of apolipoprotein B-100-containing lipoproteins in dyslipidaemias8. Sex-specific aspects of dyslipidaemia and atherosclerosis; Part III: Prevention and treatment strategies; 9. New clinical trials oflipid-regulating agents; 10. Genetics of dyslipidaemia andcoronary risk (personalized lipid-lowering treatment); 11. Application of proteomic, metabolomic and lipidomic approaches to coronary heart disease risk prediction; 12. N. Lipid disorders are highly heterogeneous and widely prevalent throughout the world. Dyslipidemia is an important risk factor for atherosclerotic disease and its clinical sequelae, including myocardial infarction, ischemic stroke, and death. The impact of dyslipidemia treatment on risk for cardiovascular disease is one of the most intensively studied issues in all of medicine. This volume is an innovative approach to the identification and management of lipid disorders. Organized as a series of questions, each chapter presents a detailed yet accessible discussion of the problems posed. The ques MEDICAL / Endocrinology & Metabolism bisacsh MEDICAL / Nutrition bisacsh Lipids / Metabolism / Disorders fast Dyslipidemias / diagnosis Dyslipidemias / therapy Medizin Lipids Metabolism Disorders Sica, Domenic A. Sonstige oth http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=244612 Aggregator Volltext |
| spellingShingle | Toth, Peter P. Clinical challenges in lipid disorders MEDICAL / Endocrinology & Metabolism bisacsh MEDICAL / Nutrition bisacsh Lipids / Metabolism / Disorders fast Dyslipidemias / diagnosis Dyslipidemias / therapy Medizin Lipids Metabolism Disorders |
| title | Clinical challenges in lipid disorders |
| title_auth | Clinical challenges in lipid disorders |
| title_exact_search | Clinical challenges in lipid disorders |
| title_full | Clinical challenges in lipid disorders edited by Peter P. Toth and Domenic A. Sica |
| title_fullStr | Clinical challenges in lipid disorders edited by Peter P. Toth and Domenic A. Sica |
| title_full_unstemmed | Clinical challenges in lipid disorders edited by Peter P. Toth and Domenic A. Sica |
| title_short | Clinical challenges in lipid disorders |
| title_sort | clinical challenges in lipid disorders |
| topic | MEDICAL / Endocrinology & Metabolism bisacsh MEDICAL / Nutrition bisacsh Lipids / Metabolism / Disorders fast Dyslipidemias / diagnosis Dyslipidemias / therapy Medizin Lipids Metabolism Disorders |
| topic_facet | MEDICAL / Endocrinology & Metabolism MEDICAL / Nutrition Lipids / Metabolism / Disorders Dyslipidemias / diagnosis Dyslipidemias / therapy Medizin Lipids Metabolism Disorders |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=244612 |
| work_keys_str_mv | AT tothpeterp clinicalchallengesinlipiddisorders AT sicadomenica clinicalchallengesinlipiddisorders |